ČESKÁ UROLOGIE / CZECH UROLOGY – 2 / 2023

85 Ces Urol 2023; 27(2): 78-85 PŘEHLEDOVÉ ČLÁNKY 18. Morgan TM, Welty CHJ, Funda VL, Lin DW, Wright. Ductal Adenocarcinoma of the Prostate: Increased Mortality Risk and Decreased Serum Prostate Specific Antigen. J Urol. 2010; 184(6): 2303–7. 19. Epstein JI, Allsbrook WCJ, Amin MB, Egevad LL, and the ISUP Grading Committee. The 2005 Inter‑ national Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol [Internet]. 2005; 29(9). Available from: https://journals.lww.com/ajsp/Full‑ text/2005/09000/The_2005_International_Society_of_Urological.15.aspx. 20. Conteduca V, Oromendia C, Eng KW, et al. Clinical features of neuroendocrine prostate cancer. Eur J Cancer Oxf Engl 1990. 2019; 121: 7–18. 21. Aggarwal R, Huang J, Alumkal JJ, et al. Clinical and Genomic Characterization of Treatment‑Emergent Small‑Cell Neuroendocrine Prostate Cancer: A Multi‑institutional Prospective Study. J Clin Oncol. 2018; 36(24): 2492–503. 22. Bluemn EG, Coleman IM, Lucas JM, et al. Androgen Receptor Pathway‑Independent Prostate Cancer Is Sustained through FGF Signaling. Cancer Cell. 2017; 32(4): 474–489.e6. 23. Wang HT, Yao YH, Li BG. Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis – A Systematic Review and Pooled Analysis. J Clin Oncol. 2014; 32(30): 3383–90. 24. Park JW, Lee JK, Sheu KM, et al. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018; 362(6410): 91–5. 25. Epstein JI, Amin MB, Beltran H, et al. Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation. Am J Surg Pathol. 2014; 38(6): 756–67. 26. Magers MJ, Iczkowski KA, Montironi R, et al. MYB‑NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia. Mod Pathol. 2019; 32(11): 1666–74.

RkJQdWJsaXNoZXIy NDA4Mjc=